SCHEMBL24372783

SCHEMBL24372783

CC1CCCCN1/C=C\CN

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.30
HPGD P15428 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8575220 0.75 GAA (0.32) ALDH1A1GAASMN1; SMN2MEN1HPGD
SCHEMBL8574132 0.75 GAA (0.32) ALDH1A1GAASMN1; SMN2MEN1HPGD
SCHEMBL1218493 0.70
SCHEMBL645411 0.69 CHRNB2 (0.34) ALDH1A1GAASMN1; SMN2HPGD
SCHEMBL10763256 0.69
SCHEMBL12224195 0.69
SCHEMBL11821263 0.69
SCHEMBL6859302 0.69
SCHEMBL2111705 0.69
SCHEMBL25045003 0.67 GAA (0.32) ALDH1A1GAASMN1; SMN2MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988089-A1 LIPID NANOPARTICLES FOR IN-VIVO DRUG DELIVERY, AND USES THEREOF EnhancedBio Inc. (KR) 2022-04-27 EP disclosed